Showing results (701-710 of 1,019) with videos related to

Sort By:
Pageof 102
Avian Diseases|April 18, 2025
Avibacterium paragallinarum, the Causative Agent of Infectious Coryza: A Comprehensive ReviewMohamed El-Gazzar, Rodrigo Gallardo, Robert Bragg, et al.
The Journal of Clinical Ethics|August 11, 2020
Phases of a Pandemic Surge: The Experience of an Ethics Service in New York City during COVID-19Barrie J Huberman, Debjani Mukherjee, Ezra Gabbay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Neuron|August 27, 2011
Cadherin-6 mediates axon-target matching in a non-image-forming visual circuitJessica A Osterhout, Nicko Josten, Jena Yamada, et al.
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
Cell|December 18, 2007
The classical complement cascade mediates CNS synapse eliminationBeth Stevens, Nicola J Allen, Luis E Vazquez, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
Journal of the National Cancer Institute|February 3, 2016
Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian CarcinomasAnne M Schultheis, Charlotte K Y Ng, Maria R De Filippo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung CancerLorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarkerM Catherine Pietanza, Kyuichi Kadota, Kety Huberman, et al.
Pageof 102